
- Pharmaceutical Executive-06-01-2009
- Volume 0
- Issue 0
Jennifer Spear Smith, Wyeth
Jennifer Spear Smith may be soft-spoken and petite, but she is loud, clear, and stands tall for one part of industry that she is clearly passionate about: continuing medical education (CME).
JENNIFER SPEAR SMITH
Executive Director, Medical Education, Wyeth
(JOHN HALPERN)
Jennifer Spear Smith may be soft-spoken and petite, but she is loud, clear, and stands tall for one part of industry that she is clearly passionate about: continuing medical education (CME).
Prior to her current position as executive director of medical education for Wyeth, Spear Smith was a CME provider and before that a professor in physiology at Indiana University and Purdue University's combined medical school program. "Medical school was just a starting point for me," says Spear Smith. "Things change so differently in medicine. There is a system, but it needs improvement so that physicians can be helping patients. That is the reason I go to work every day, to improve patient care."
Spear Smith was attracted to the pharma industry for the ample resources available to guide CME in a direction where she could "make a difference in patient care." And she already has by helping to make Wyeth one of the first pharmaceutical companies to require CME providers, after they conducted a CME activity, to measure its success.
"In 10 years, I hope I am still involved in managing education of physicians where it's my goal to continue in a position that ultimately helps patient care," Spear Smith says. "A pharma company is in the perfect position to make a change with how they conduct business and really gear it toward patient care. When we can do that we will have really revolutionized the business."
Articles in this issue
over 16 years ago
Hans Bishop, Bayer Healthcareover 16 years ago
Stefan Platz, Rocheover 16 years ago
Virginia Carden Carnahan, Vertex Pharmaceuticalsover 16 years ago
Jeffrey Tong, Infinity Pharmaceuticalsover 16 years ago
Elizabeth Mutisya, Solvay Pharmaceuticalsover 16 years ago
On the Right Pathwaysover 16 years ago
Craig Dashefsky, Schering-Ploughover 16 years ago
Joe Mclane, Merckover 16 years ago
Frank Karbe, Exelixisover 16 years ago
Michelle Dipp, GlaxoSmithKlineNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





